The publisher's "Medical Devices sector report, “Transmucosal Drug Delivery Devices - Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Transmucosal Drug Delivery Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Transmucosal Drug Delivery device is intended for the localized delivery of medications through a mucous membrane.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Transmucosal Drug Delivery device is intended for the localized delivery of medications through a mucous membrane.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Transmucosal Drug Delivery Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Transmucosal Drug Delivery Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Transmucosal Drug Delivery Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
1 Table of Contents1.1 List of Tables1.2 List of Figures
2 Introduction2.1 Transmucosal Drug Delivery Overview
3 Products under Development3.1 Transmucosal Drug Delivery - Pipeline Products by Stage of Development
3.2 Transmucosal Drug Delivery - Pipeline Products by Segment
3.3 Transmucosal Drug Delivery - Pipeline Products by Territory
3.4 Transmucosal Drug Delivery - Pipeline Products by Regulatory Path
3.5 Transmucosal Drug Delivery - Pipeline Products by Estimated Approval Date
3.6 Transmucosal Drug Delivery - Ongoing Clinical Trials
4 Transmucosal Drug Delivery - Pipeline Products under Development by Companies4.1 Transmucosal Drug Delivery Companies - Pipeline Products by Stage of Development
4.2 Transmucosal Drug Delivery - Pipeline Products by Stage of Development
5 Transmucosal Drug Delivery Companies and Product Overview5.1 AcelRx Pharmaceuticals Inc Company Overview
5.2 AFYX Therapeutics A/S Company Overview
5.3 Albert Einstein College of Medicine Company Overview
5.4 Allergan Ltd Company Overview
5.5 Altamira Medica AG Company Overview
5.6 Amphastar Pharmaceuticals Inc Company Overview
5.7 Anelleo Inc Company Overview
5.8 APR Applied Pharma Research SA Company Overview
5.9 ARS Pharmaceuticals Inc Company Overview
5.10 Auris Medical AG Company Overview
5.11 Auritec Pharmaceuticals Inc Company Overview
5.12 Bayer Healthcare LLC Company Overview
5.13 BeFree! Company Overview
5.14 Bespak Europe Ltd Company Overview
5.15 Biorings LLC Company Overview
5.16 BioXcel Therapeutics Inc Company Overview
5.17 Bryn Pharma LLC Company Overview
5.18 Callitas Therapeutics Inc Company Overview
5.19 Combinent BioMedical Systems Inc Company Overview
5.20 Conrad Company Overview
5.21 Dare Bioscience Inc Company Overview
5.22 Eledon Pharmaceuticals Inc Company Overview
5.23 Emergent BioSolutions Inc Company Overview
5.24 Ena Respiratory Pty Ltd Company Overview
5.25 Eureka Therapeutics Inc Company Overview
5.26 Evestra Inc Company Overview
5.27 EyeGate Pharmaceuticals Inc Company Overview
5.28 Ferring Pharmaceuticals AS Company Overview
5.29 Ghent University Company Overview
5.30 Glenmark Pharmaceuticals Ltd Company Overview
5.31 Grunenthal Ltd Company Overview
5.32 Hebrew University of Jerusalem Company Overview
5.33 Hikma Pharmaceuticals Plc Company Overview
5.34 Insys Therapeutics Inc (Inactive) Company Overview
5.35 IntelGenx Corp Company Overview
5.36 ITF Pharma Inc Company Overview
5.37 Janssen Sciences Ireland UC Company Overview
5.38 Karessa Pharma AB Company Overview
5.39 Kytogenics Pharmaceuticals Inc Company Overview
5.40 Laboratoire HRA Pharma SAS Company Overview
5.41 Laboratorios Andromaco Company Overview
5.42 Lyra Therapeutics Inc Company Overview
5.43 McNeil AB Company Overview
5.44 Medlab Clinical Ltd Company Overview
5.45 Merck & Co Inc Company Overview
5.46 Merck Serono SA Company Overview
5.47 Merck Sharp & Dohme Ltd Company Overview
5.48 Mithra Pharmaceuticals SA Company Overview
5.49 Mucommune LLC Company Overview
5.50 Mystic Pharmaceuticals Inc Company Overview
5.51 Nanosys Inc Company Overview
5.52 Nasus Pharma Ltd Company Overview
5.53 Nemera La Verpilliere Company Overview
5.54 NorInvent AB Company Overview
5.55 Opiant Pharmaceuticals Inc Company Overview
5.56 OptiNose AS Company Overview
5.57 OptiNose Inc Company Overview
5.58 Orion Biotechnology Canada Ltd Company Overview
5.59 Orphanse Healthcare SAS Company Overview
5.60 Oyster Point Pharma Inc Company Overview
5.61 Palette Life Sciences AB Company Overview
5.62 Phoenix Life Sciences International Ltd Company Overview
5.63 RDD Pharma Ltd (Inactive) Company Overview
5.64 Renown Pharmaceuticals Pvt Ltd Company Overview
5.65 Rhinomed Limited Company Overview
5.66 Scientus Pharma Inc Company Overview
5.67 Seelos Therapeutics, Inc. Company Overview
5.68 Shin Nippon Biomedical Laboratories Ltd Company Overview
5.69 SipNose Ltd Company Overview
5.70 Starpharma Holdings Ltd Company Overview
5.71 Suda Pharmaceuticals Ltd Company Overview
5.72 Therakind Ltd Company Overview
5.73 University of Pittsburgh Company Overview
5.74 University of South Florida Company Overview
5.75 University of Texas at Austin Company Overview
5.76 University of the Witwatersrand Company Overview
5.77 University of Washington Company Overview
5.78 VistaGen Therapeutics Inc Company Overview
5.79 Washington University in St Louis Company Overview
5.80 Xlear Inc Company Overview
5.81 Zosano Pharma Corp Company Overview
5.82 Zydus Healthcare Ltd Company Overview
6 Transmucosal Drug Delivery- Recent Developments
7 Appendix7.1 Methodology
7.2 About the Publisher
7.4 Disclaimer
List of Tables
- Transmucosal Drug Delivery - Pipeline Products by Stage of Development
- Transmucosal Drug Delivery - Pipeline Products by Segment
- Transmucosal Drug Delivery - Pipeline Products by Territory
- Transmucosal Drug Delivery - Pipeline Products by Regulatory Path
- Transmucosal Drug Delivery - Pipeline Products by Estimated Approval Date
- Transmucosal Drug Delivery - Ongoing Clinical Trials
- Transmucosal Drug Delivery Companies - Pipeline Products by Stage of Development
- Transmucosal Drug Delivery - Pipeline Products by Stage of Development
- Glossary
List of Figures
- Transmucosal Drug Delivery - Pipeline Products by Stage of Development
- Transmucosal Drug Delivery - Pipeline Products by Segment
- Transmucosal Drug Delivery - Pipeline Products by Territory
- Transmucosal Drug Delivery - Pipeline Products by Regulatory Path
- Transmucosal Drug Delivery - Pipeline Products by Estimated Approval Date
- Transmucosal Drug Delivery - Ongoing Clinical Trials
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AcelRx Pharmaceuticals Inc
- AFYX Therapeutics A/S
- Albert Einstein College of Medicine
- Allergan Ltd
- Altamira Medica AG
- Amphastar Pharmaceuticals Inc
- Anelleo Inc
- APR Applied Pharma Research SA
- ARS Pharmaceuticals Inc
- Auris Medical AG
- Auritec Pharmaceuticals Inc
- Bayer Healthcare LLC
- BeFree!
- Bespak Europe Ltd
- Biorings LLC
- BioXcel Therapeutics Inc
- Bryn Pharma LLC
- Callitas Therapeutics Inc
- Combinent BioMedical Systems Inc
- Conrad
- Dare Bioscience Inc
- Eledon Pharmaceuticals Inc
- Emergent BioSolutions Inc
- Ena Respiratory Pty Ltd
- Eureka Therapeutics Inc
- Evestra Inc
- EyeGate Pharmaceuticals Inc
- Ferring Pharmaceuticals AS
- Ghent University
- Glenmark Pharmaceuticals Ltd
- Grunenthal Ltd
- Hebrew University of Jerusalem
- Hikma Pharmaceuticals Plc
- Insys Therapeutics Inc (Inactive)
- IntelGenx Corp
- ITF Pharma Inc
- Janssen Sciences Ireland UC
- Karessa Pharma AB
- Kytogenics Pharmaceuticals Inc
- Laboratoire HRA Pharma SAS
- Laboratorios Andromaco
- Lyra Therapeutics Inc
- McNeil AB
- Medlab Clinical Ltd
- Merck & Co Inc
- Merck Serono SA
- Merck Sharp & Dohme Ltd
- Mithra Pharmaceuticals SA
- Mucommune LLC
- Mystic Pharmaceuticals Inc
- Nanosys Inc
- Nasus Pharma Ltd
- Nemera La Verpilliere
- NorInvent AB
- Opiant Pharmaceuticals Inc
- OptiNose AS
- OptiNose Inc
- Orion Biotechnology Canada Ltd
- Orphanse Healthcare SAS
- Oyster Point Pharma Inc
- Palette Life Sciences AB
- Phoenix Life Sciences International Ltd
- RDD Pharma Ltd (Inactive)
- Renown Pharmaceuticals Pvt Ltd
- Rhinomed Limited
- Scientus Pharma Inc
- Seelos Therapeutics, Inc.
- Shin Nippon Biomedical Laboratories Ltd
- SipNose Ltd
- Starpharma Holdings Ltd
- Suda Pharmaceuticals Ltd
- Therakind Ltd
- University of Pittsburgh
- University of South Florida
- University of Texas at Austin
- University of the Witwatersrand
- University of Washington
- VistaGen Therapeutics Inc
- Washington University in St Louis
- Xlear Inc
- Zosano Pharma Corp
- Zydus Healthcare Ltd
